Research Database

69 studies found

Positive

59

85.5%

Negative

2

2.9%

Inconclusive

8

11.6%

Page 4 of 4

PositiveAnimal Study -

Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model

2016

Alzheimer's DiseaseDementiaNeurodegenerative Issues

PositiveReview/Other

Safety And Efficacy Of Medical Cannabis Oil For Behavioral And Psychological Symptoms Of Dementia: An-Open Label, Add-On, Pilot Study

2016

Alzheimer's Disease

PositiveDouble Blind Clinical Trial

Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial

2015

Alzheimer's Disease

InconclusiveDouble Blind Clinical Trial

Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial

2015

Behavioral Disorders

PositiveLaboratory Study -

Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia

2015

Alzheimer's Disease

InconclusiveReview/Other

Cannabinoids for the treatment of dementia

2009

Anorexia

PositiveLaboratory Study -

The Activation Of Cannabinoid CB2 Receptors Stimulates In Situ And In Vitro Beta-amyloid Removal By Human Macrophages

2009

Alzheimer's Disease

PositiveReview/Other

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.

2006

Cognitive Dysfunction

PositiveReview/Other

Cannabis Indica

1890

Alzheimer's Disease

Behavioral Disorders

Cognitive Dysfunction

+2

Behavioral Disorders

Cognitive Dysfunction

+5

Dementia

Alzheimer's Disease

Anorexia

Cancer

+9

Dementia

Neurodegenerative Issues

+5

Dementia

Geriatric Conditions

+1

Arthritis - Gout

Arthritis

+7

4

Command Palette

Research Database

Delineating the Efficacy of a Cannabis-Based Medicine at Advanced Stages of Dementia in a Murine Model

Safety And Efficacy Of Medical Cannabis Oil For Behavioral And Psychological Symptoms Of Dementia: An-Open Label, Add-On, Pilot Study

Tetrahydrocannabinol for neuropsychiatric symptoms in dementia: A randomized controlled trial

Tetrahydrocannabinol in Behavioral Disturbances in Dementia: A Crossover Randomized Controlled Trial

Safety, pharmacodynamics, and pharmacokinetics of multiple oral doses of delta-9-tetrahydrocannabinol in older persons with dementia

Cannabinoids for the treatment of dementia

The Activation Of Cannabinoid CB2 Receptors Stimulates In Situ And In Vitro Beta-amyloid Removal By Human Macrophages

Delta-9-tetrahydrocannabinol for nighttime agitation in severe dementia.

Cannabis Indica